In this study, investigators found that patients with MAFLD with intermediate or high fibrosis 4 (FIB-4) scores were older and more obese and have a higher prevalence of diabetes, a higher level of liver enzymes, a higher level of C-reactive protein (CRP), and a lower level of lymphocyte count compared to patients without MAFLD or with low FIB-4 scores. The gene discussed is CRP; the disease is diabetes mellitus.